| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 9 | 3 | 13 |
| 5-hydroxytryptamine receptor 1B | 0 | 7 | 1 | 8 |
| 5-hydroxytryptamine receptor 1D | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 1F | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 6 | 0 | 0 | 1 | 1 |
| Sodium-dependent serotonin transporter | 0 | 6 | 1 | 7 |
| Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 7 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 5A | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 5B | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 3B | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 7 | 0 | 7 |
| Beta-2 adrenergic receptor | 0 | 10 | 7 | 18 |
| Beta-1 adrenergic receptor | 0 | 12 | 6 | 18 |
| Beta-3 adrenergic receptor | 0 | 4 | 6 | 10 |
| thioredoxin reductase | 7 | 0 | 0 | 7 |
| USP1 protein, partial | 1 | 0 | 0 | 1 |
| Microtubule-associated protein tau | 3 | 0 | 0 | 3 |
| lamin isoform A-delta10 | 6 | 0 | 0 | 6 |
| ATP-binding cassette sub-family C member 3 | 0 | 9 | 0 | 9 |
| Multidrug resistance-associated protein 4 | 0 | 9 | 0 | 10 |
| Bile salt export pump | 0 | 13 | 0 | 13 |
| Canalicular multispecific organic anion transporter 1 | 0 | 9 | 0 | 9 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 3 | 0 | 0 | 3 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
| Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
| Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
| Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
| Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
| GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
| ras protein, partial | 0 | 0 | 1 | 1 |
| interleukin 8 | 1 | 0 | 0 | 1 |
| GLS protein | 6 | 0 | 0 | 6 |
| AR protein | 7 | 0 | 0 | 7 |
| aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
| thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 5 | 0 | 0 | 5 |
| EWS/FLI fusion protein | 5 | 0 | 0 | 5 |
| glucocorticoid receptor [Homo sapiens] | 4 | 0 | 0 | 4 |
| retinoic acid nuclear receptor alpha variant 1 | 3 | 0 | 0 | 3 |
| estrogen-related nuclear receptor alpha | 3 | 0 | 0 | 3 |
| estrogen nuclear receptor alpha | 5 | 0 | 0 | 5 |
| cytochrome P450 2D6 | 4 | 0 | 0 | 4 |
| glucocerebrosidase | 2 | 0 | 0 | 2 |
| peroxisome proliferator-activated receptor delta | 1 | 0 | 0 | 1 |
| Rac1 protein | 0 | 0 | 1 | 1 |
| IDH1 | 2 | 0 | 0 | 2 |
| cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
| euchromatic histone-lysine N-methyltransferase 2 | 10 | 0 | 0 | 10 |
| Bloom syndrome protein isoform 1 | 3 | 0 | 0 | 3 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
| DNA polymerase iota isoform a (long) | 3 | 0 | 0 | 3 |
| DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
| muscarinic acetylcholine receptor M1 | 3 | 0 | 0 | 3 |
| lethal factor (plasmid) | 1 | 0 | 0 | 1 |
| Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
| Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
| Integrin beta-3 | 0 | 1 | 0 | 1 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
| Integrin alpha-IIb | 0 | 1 | 0 | 1 |
| Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 1 | 1 | 2 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
| Urotensin-2 receptor | 0 | 1 | 0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-gamma | 1 | 0 | 0 | 1 |
| Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 2 | 2 | 2 | 6 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
| Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 8 | 1 | 9 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 1 | 2 |
| regulator of G-protein signaling 4 | 7 | 0 | 0 | 7 |
| Beta-1 adrenergic receptor | 0 | 1 | 4 | 7 |
| D(1A) dopamine receptor | 4 | 0 | 0 | 4 |
| geminin | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit pi | 2 | 1 | 2 | 5 |
| Urease | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 2 | 1 | 2 | 5 |
| Gamma-aminobutyric acid receptor subunit delta | 2 | 1 | 2 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 2 | 1 | 2 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 2 | 1 | 2 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 2 | 1 | 2 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 2 | 1 | 2 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 2 | 1 | 2 | 5 |
| Alpha-1D adrenergic receptor | 0 | 5 | 4 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 2 | 1 | 2 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 2 | 1 | 2 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 2 | 1 | 2 | 5 |
| Alpha-1A adrenergic receptor | 0 | 4 | 5 | 10 |
| Alpha-1B adrenergic receptor | 0 | 3 | 4 | 8 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 2 | 1 | 2 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 2 | 1 | 2 | 5 |
| TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 2 | 5 | 8 |
| GABA theta subunit | 2 | 1 | 2 | 5 |
| Gamma-aminobutyric acid receptor subunit epsilon | 2 | 1 | 2 | 5 |
| ATP-dependent phosphofructokinase | 5 | 0 | 0 | 5 |
| Atrial natriuretic peptide receptor 1 | 0 | 1 | 1 | 2 |
| Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
| Potassium channel subfamily K member 3 | 0 | 2 | 0 | 2 |
| Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 2 | 0 | 1 | 1 | 2 |
| Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 5 | 0 | 0 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 2 | 0 | 2 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 2 | 0 | 2 |
| acetylcholinesterase | 2 | 0 | 0 | 2 |
| nonstructural protein 1 | 1 | 0 | 0 | 1 |
| arylsulfatase A | 4 | 0 | 0 | 4 |
| activating transcription factor 6 | 4 | 0 | 0 | 4 |
| peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform a | 1 | 0 | 0 | 1 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 5 | 0 | 0 | 5 |
| importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
| snurportin-1 | 1 | 0 | 0 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
| histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 7 | 0 | 4 | 0 | 4 |
| Spike glycoprotein | 3 | 0 | 0 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 3 | 0 | 3 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 8 | 0 | 8 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 3 | 0 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 4 | 0 | 4 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| glp-1 receptor, partial | 3 | 0 | 0 | 3 |
| 15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
| RAR-related orphan receptor gamma | 3 | 0 | 0 | 3 |
| ATAD5 protein, partial | 3 | 0 | 0 | 3 |
| NFKB1 protein, partial | 1 | 0 | 0 | 1 |
| thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
| serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
| cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
| vitamin D3 receptor isoform VDRA | 2 | 0 | 0 | 2 |
| serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
| peripheral myelin protein 22 | 2 | 0 | 0 | 2 |
| cytochrome P450 3A4 isoform 1 | 2 | 0 | 0 | 2 |
| M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
| muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 1 | 0 | 1 | 2 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
| Endothelin-1 receptor | 0 | 1 | 0 | 1 |
| Luciferase | 1 | 0 | 0 | 1 |
| TDP1 protein | 6 | 0 | 0 | 6 |
| pregnane X nuclear receptor | 2 | 0 | 0 | 2 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 6 | 1 | 14 |
| D(2) dopamine receptor | 0 | 3 | 1 | 4 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 2 | 0 | 2 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 4 | 0 | 5 |
| Delta-type opioid receptor | 0 | 4 | 1 | 6 |
| Mu-type opioid receptor | 0 | 5 | 2 | 10 |
| Kappa-type opioid receptor | 0 | 3 | 1 | 5 |
| Histamine H1 receptor | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 5 | 3 | 9 |
| D(3) dopamine receptor | 0 | 4 | 0 | 4 |
| Delta-type opioid receptor | 0 | 5 | 2 | 8 |
| Kappa-type opioid receptor | 0 | 5 | 0 | 5 |
| Kappa-type opioid receptor | 0 | 5 | 2 | 8 |
| Mu-type opioid receptor | 0 | 3 | 1 | 6 |
| Mu-type opioid receptor | 0 | 4 | 0 | 4 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Cellular tumor antigen p53 | 2 | 0 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
| phosphopantetheinyl transferase | 2 | 0 | 0 | 2 |
| GLI family zinc finger 3 | 3 | 0 | 0 | 3 |
| nuclear receptor subfamily 1, group I, member 3 | 2 | 0 | 0 | 2 |
| NPYLR7B | 0 | 0 | 1 | 1 |
| Histone H2A.x | 1 | 0 | 0 | 1 |
| beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| chromobox protein homolog 1 | 3 | 0 | 0 | 3 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 2 | 0 | 0 | 2 |
| Bile salt export pump | 0 | 3 | 0 | 3 |
| Beta-2 adrenergic receptor | 0 | 4 | 1 | 6 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 5 | 3 | 8 |
| Beta-1 adrenergic receptor | 0 | 4 | 2 | 8 |
| Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
| Alpha-2B adrenergic receptor | 0 | 4 | 4 | 8 |
| D(1A) dopamine receptor | 0 | 2 | 1 | 3 |
| Alpha-2C adrenergic receptor | 0 | 4 | 4 | 8 |
| Alpha-2A adrenergic receptor | 0 | 4 | 4 | 8 |
| Alpha-1D adrenergic receptor | 0 | 5 | 3 | 9 |
| Beta-adrenergic receptor kinase 1 | 0 | 0 | 1 | 1 |
| Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
| Beta-3 adrenergic receptor | 0 | 3 | 1 | 4 |
| Vasopressin V1a receptor | 0 | 0 | 1 | 1 |
| Beta-1 adrenergic receptor | 0 | 2 | 1 | 3 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 1 | 1 |
| Alpha-1A adrenergic receptor | 0 | 5 | 3 | 8 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 3 | 0 | 3 |
| Taste receptor type 2 member 38 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 39 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 40 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 41 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 43 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 31 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 45 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 46 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 30 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 19 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 20 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 50 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 60 | 0 | 0 | 1 | 1 |
| Oxytocin receptor | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 1 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 2 | 3 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 42 | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 16 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 14 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 13 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 10 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 9 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 8 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 7 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 5 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 4 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 3 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 1 | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 1 | 1 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 1 | 0 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2D6 | 0 | 3 | 0 | 3 |
| Sodium-dependent noradrenaline transporter | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 2B | 0 | 8 | 1 | 9 |
| Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
| Ataxin-2 | 4 | 0 | 0 | 4 |
| Heparanase | 0 | 0 | 1 | 1 |
| Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 1 | 0 | 0 | 1 |
| mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
| flap endonuclease 1 | 1 | 0 | 0 | 1 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 5 subunit alpha | 0 | 3 | 0 | 3 |
| Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
| Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Opioid receptor homologue | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| Cytochrome P450 3A4 | 0 | 3 | 1 | 4 |
| Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 5 | 4 | 11 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
| Translocator protein | 0 | 0 | 1 | 1 |
| Histidine decarboxylase | 0 | 0 | 1 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 3 |
| Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
| Kappa-type opioid receptor | 0 | 2 | 1 | 4 |
| UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
| Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
| Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
| ClpP | 1 | 0 | 0 | 1 |
| Hsf1 protein | 0 | 0 | 1 | 1 |
| bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
| cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
| thyroid hormone receptor beta isoform 2 | 2 | 0 | 0 | 2 |
| estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
| urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
| plasminogen precursor | 1 | 0 | 0 | 1 |
| urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 6 | 0 | 6 |
| Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
| Alpha-2B adrenergic receptor | 0 | 2 | 2 | 6 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 3 | 3 | 8 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 6 | 1 | 7 |
| 5-hydroxytryptamine receptor 2C | 0 | 6 | 1 | 7 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
| Nischarin | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 2 | 3 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Adenosine receptor A3 | 0 | 1 | 1 | 2 |
| Cytochrome P450 2C8 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 1 | 2 |
| Cytochrome P450 2C9 | 0 | 2 | 0 | 2 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 1 | 1 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Endothelin-1 receptor | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 1 | 3 |
| Adenosine receptor A2a | 0 | 1 | 1 | 2 |
| Neuromedin-K receptor | 0 | 0 | 1 | 1 |
| Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
| Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
| Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 1 | 2 |
| Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 6 | 0 | 2 | 1 | 3 |
| Cytochrome P450 2J2 | 0 | 2 | 0 | 2 |
| Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
| POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
| progesterone receptor | 1 | 0 | 0 | 1 |
| G | 1 | 0 | 0 | 1 |
| peroxisome proliferator activated receptor gamma | 1 | 0 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
| huntingtin isoform 2 | 1 | 0 | 0 | 1 |
| Interferon beta | 1 | 0 | 0 | 1 |
| HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
| Glycoprotein | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
| Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 0 | 2 | 0 | 2 |
| Multidrug resistance-associated protein 1 | 0 | 2 | 1 | 4 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
| Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 1 | 2 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 2 |
| cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |